Neuromyelitis Optica Treatments

Find Neuromyelitis Optica Treatments

Generic Name

Eculizumab

Brand Names
BKEMV, Epysqli, Soliris
FDA approval date: April 02, 2007
Classification: Complement Inhibitor
Form: Injection

What is BKEMV (Eculizumab)?

BKEMV is a complement inhibitor indicated for: The treatment of patients with paroxysmal nocturnal hemoglobinuria to reduce hemolysis.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Prospective Cohort Study of cLinical and Imaging Patterns of neUroinflammation disEases (CLUE)

Summary: CLUE is a prospective study to assess structural and functional changes of the brain, spinal cord, and optic nerve, as well as the inflammatory environment in patients with neuroinflammatory and demyelinating diseases. Participants will receive magnetic resonance (MR) techniques including DIR, DKI, QSM, Rs-fMRI, conventional sequences (T1WI/T2WI/FLAIR), and the MR metabolic SPICE sequence, and wil...

Danicopan Regulatory Post-Marketing Study in Korea

Summary: As part of a post-approval commitment, the Korean health authority requests a study to characterize safety and effectiveness in patients who are treated with Danicopan as an add-on to ravulizumab or eculizumab in normal clinical practice settings. This study is designed to assess the known safety profile or identify previously unsuspected adverse reactions and to evaluate the effectiveness of Dani...

Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Randomized Controlled Trial Study

Summary: Study Title: A National, Multicenter, Randomized Controlled Trial of the Modified Zipper Therapy in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (ELITE Study) Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of a novel sequential immunomodulation strategy, termed Modified Zipper Therapy, in patients with acute attacks of Aquaporin-4 antibody-po...

Brand Information